Polymorphism rs4919510:C> in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Huang, A Ji ^a   Yu, Ke Da ^a   Li, Jing ^a   Fan, Lei ^a   Shao, Zhi Ming ^a  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GUANINE; MICRORNA; MICRORNA 608; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; HEAT SHOCK TRANSCRIPTION FACTOR; HER2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HSF1 GENE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PREDICTION; RISK ASSESSMENT; RNA SEQUENCE; TUMOR GROWTH; AGED; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; NEOPLASM; PATHOLOGY; RISK FACTOR; STATISTICAL MODEL;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MICRORNAS; MIDDLE AGED; NEOPLASMS, HORMONE-DEPENDENT; POLYMORPHISM, GENETIC; RECEPTOR, ERBB-2; RISK FACTORS; TRANSCRIPTION FACTORS;

EID: 84860607712     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035252     Document Type: Article

References (18)

1. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
2. Hu Z, Liang J, Wang Z, Tian T, Zhou X, et al. (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30: 79-84.
3. Li W, Duan R, Kooy F, Sherman SL, Zhou W, et al. (2009) Germline mutation of microRNA-125a is associated with breast cancer. J Med Genet 46: 358-360.
4. Peterlongo P, Caleca L, Cattaneo E, Ravagnani F, Bianchi T, et al. (2011) The rs12975333 variant in the miR-125a and breast cancer risk in Germany, Italy, Australia and Spain. J Med Genet 48: 703-704.
5. Landi D, Gemignani F, Barale R, Landi S, (2008) A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA Cell Biol 27: 35-43.
6. Knowlden JM, Gee JM, Barrow D, Robertson JF, Ellis IO, et al. (2011) erbB3 recruitment of insulin receptor substrate-1 impacts on insulin-like growth factor receptor signalling in oestrogen receptor positive breast cancer cell lines. Breast Cancer Res 13: R93.
7. Hefler LA, Grimm C, Lantzsch T, Lampe D, Leodolter S, et al. (2005) Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women. Clin Cancer Res 11: 5718-5721.
8. Canzian F, Cox DG, Setiawan VW, Stram DO, Ziegler RG, et al. (2010) Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Hum Mol Genet 19: 3873-3884.
9. Hu Z, Li X, Yuan R, Ring BZ, Su L, (2010) Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis. Breast Cancer Res Treat 120: 705-714.
10. Chen AX, Yu KD, Fan L, Li JY, Yang C, et al. (2011) Germline Genetic Variants Disturbing the Let-7/LIN28 Double-Negative Feedback Loop Alter Breast Cancer Susceptibility. PLoS Genet 7: e1002259.
11. Yu KD, Di GH, Yuan WT, Fan L, Wu J, et al. (2009) Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53. Hum Mol Genet 18: 2502-2517.
12. Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, et al. (2009) Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients. Breast Cancer Res Treat 115: 325-333.
13. Li WF, Hu Z, Rao NY, Song CG, Zhang B, et al. (2008) The prevalence of BRCA1 and BRCA2 germline mutations in high-risk breast cancer patients of Chinese Han nationality: two recurrent mutations were identified. Breast Cancer Res Treat 110: 99-109.
14. Meng L, Gabai VL, Sherman MY, (2010) Heat-shock transcription factor HSF1 has a critical role in human epidermal growth factor receptor-2-induced cellular transformation and tumorigenesis. Oncogene 29: 5204-5213.
15. Zhao YH, Zhou M, Liu H, Ding Y, Khong HT, et al. (2009) Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. Oncogene 28: 3689-3701.
16. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, et al. (2010) Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507.
17. Latif A, Hadfield KD, Roberts SA, Shenton A, Lalloo F, et al. (2010) Breast cancer susceptibility variants alter risks in familial disease. J Med Genet 47: 126-131.
18. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, et al. (2011) Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 20: 3289-3303.